We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

2nd Circuit Rejects Antitrust, Lanham Act Claims Involving Drug

Mealey's (May 17, 2016, 11:53 AM EDT) -- NEW YORK — A false advertising and antitrust dispute between two drug makers over the efficacy of tablets and capsules in controlling somnolence — a common side effect for users of the anti-spasticity drug tizanidine — was properly resolved by two New York federal judges, the Second Circuit U.S. Court of Appeals concluded May 16 (Apotex Inc. v. Acorda Therapeutics Inc., No. 14-4353, 2nd Cir.; 2016 U.S. App. LEXIS 8915).

(Decision available. Document #16-160606-003Z.)

According to the panel of Circuit Judges Dennis Jacobs, Debra Ann Livingston...
To view the full article, register now.